Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term glucocorticoid adjuvant therapy in patients with community-acquired pneumonia
ChiCTR-IPR-16008419Phase 4Not yet recruiting
- Sponsor
- Jiashan First People's Hospital
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in community-acquired pneumonia (CAP) comparing Conventional therapy + dexamethasone with Conventional therapy + placebo (2 arms). Primary endpoint: Time to clinical stability. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR-IPR-16008419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008419.